Does antenatal steroids treatment in twin pregnancies prior to late preterm birth reduce neonatal morbidity? Evidence fr
- PDF / 472,192 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 2 Downloads / 184 Views
MATERNAL-FETAL MEDICINE
Does antenatal steroids treatment in twin pregnancies prior to late preterm birth reduce neonatal morbidity? Evidence from a retrospective cohort study Alon Ben‑David1 · Rita Zlatkin2 · Shiran Bookstein‑Peretz1 · Raanan Meyer1 · Shali Mazaki‑Tovi1 · Yoav Yinon1 Received: 10 March 2020 / Accepted: 25 July 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Purpose To evaluate whether antenatal corticosteroids (ACS) administration during the late-preterm (LPT) period in twin pregnancies is associated with decreased rate of neonatal morbidity. Methods A retrospective cohort study including a total of 290 women with twin pregnancies resulting in live births of 580 neonates who delivered during LPT period between 2016 and 2018 at a tertiary medical center. Patients were allocated into two groups according to ACS exposure. Obstetric and neonatal outcomes were compared between the groups. Primary outcome was neonatal composite respiratory morbidity, defined as the occurrence of at least one of the followings: RDS, TTN, O2 requirement, CPAP use or mechanical ventilation. Results Patients exposed to ACS were older and more commonly complicated by gestational diabetes compared to the nonexposed group. Moreover, women exposed to ACS delivered earlier (35.6 vs. 36.3 weeks, P
Data Loading...
